Clinicoradiological differentiation of TERT promoter-mutant molecular glioblastoma versus histological glioblastoma: a single-center cohort study of 105 IDH-wildtype tumors.

Abstract excerpt

To compare the clinicopathological and magnetic resonance imaging (MRI) characteristics and prognostic implications between molecular glioblastoma (mol-GBM) and histological glioblastoma (hist-GBM) according to the 2021 WHO classification of central nervous system tumors (CNS5), we conducted a retrospective study of 105 patients with IDH-wildtype gliomas diagnosed between 2016 and 2022. Patients were reclassified...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aged
• Share to Brain Neoplasms